Innovation for Health - 13 February 2020
Contact I4H Bootcamp Global Investor Forum
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Jan de Kerpel

Managing Director, Head of Life Science & Healthcare, Kempen & Co


Dr Jan De Kerpel is a recognized biotech/healthcare business and finance expert with more than 20 years of experience in the fields of drug development, equity analysis and capital market growth financing. He currently serves as Managing Director Corporate Finance Life Science/Healthcare at Kempen. Prior to Kempen, he was during one decade Senior Equity Analyst, Pharma & Biotech at KBC Securities, which earned him 3 times the Financial Times/Starmine “Best European Biotech analyst” award. He started his professional activities in drug development at Tibotec-Virco (now JNJ) and Devgen (now Syngenta).

Jan has a proven track record in successfully identifying investment opportunities to a continuously expanding international investor base and has been instrumental in raising close to €1 billion in IPOs and other equity financing for numerous Benelux biotech, medtech, health services and pharmaceutical companies. Until recently, Jan served as board member of FlandersBio and is an invited speaker on topics relating healthcare innovation, strategic development with financing.

Academically, Jan earned a master and PhD in life sciences (Univ Leuven), postgraduate in Business Administration (Univ Leuven) and an executive MBA (Vlerick Business School), complemented with corporate finance classes (Univ Brussels).
Marcel Levi
University College London Hospitals

13 February
Jan van de Winkel
Genmab

13 February
Annemarie Jorritsma
NVP

13 February
Ton Rijnders
Lygature & Oncode Institute

13 February
Koen Kas
UGhent & HealthSkouts

13 February
Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix

12 & 13 February

Claudia Rijcken
pharmi

13 February

Inge Huitinga
Netherlands Brain Bank

13 February
Wiro Niessen
Erasmus MC, TU Delft & Quantib

13 February
Els Beirnaert
Aelin Therapeutics

13 February
Joep Muijrers
PureTech Health

13 February
Koenraad Wiedhaup
McKinsey & Company

12 & 13 February
Esther Talboom-Kamp
Saltro Diagnostics

13 February
Elise Meijer
Antwerp Management School & Accenture Strategy

13 February
Carine van den Brink
Axon Lawyers

12 February
Tim Knotnerus
AgomAb Therapeutics

13 February
Sjaak Vink
TheSocialMedwork

13 February
Hans Schikan
Topsector Life Sciences & Health

13 February
Thijn Brummelkamp
Scenic Biotech

13 February
Nadine Rouleaux
Maastricht University

13 February
Charlotte Kluit
MSD

13 February
Dharminder Chahal
SkylineDx, Van Herk Investments, Swanbridge

13 February

Marianne van der Steen
RegMedXB & Maastricht University

12 & 13 February

Jan de Kerpel
Kempen & Co

13 February

Wim Van Hecke
icoMetrix

13 February
Wiesje van der Flier 
Alzheimercentrum Amsterdam

13 February
Niels Prins
Brain Research Center & Alzheimercentrum Amsterdam

13 February
Marco Blom
Alzheimer Nederland
Edwin Moses
Achilles Therapeutics & Evox Therapeutics
Carl Moons
Health Innovation Initiative Holland
Jan Kimpen
Philips
Linda van de Burgwal 
Vrije Universiteit Amsterdam
Onno van de Stolpe
Galapagos
Ton van der Steen
Erasmus MC, Medical Delta & STW
Sangbreeta Moitra 
Founder, International Keynote Speaker & Global Strategist
Eline Vrijland-van Beest
NightBalance & Philips
Kim Peters
Healthnovum
Gideon Bevelander
Johnson & Johnson Innovation
Giuseppe Marzio
Chiaro
Wijnand IJsselsteijn
Eindhoven University of Technology
Francesco De Rubertis
Medicxi
André van de Sande
André van de Sande Consultancy BV
Travis McCready
President and CEO, Massachusetts Life Sciences Center

12 & 13 February
Kees van der Klauw
e/MTIC & NL AI Coalition

13 February
Maroeska Rovers
Health Innovation Initiative Holland

13 February
Christina Takke 
V-Bio Centures

12 February
Focco Vijselaar 
Ministerie van Economische Zaken en Klimaat

13 February
Juliette Audet 
Forbion

12 February
Felice Verduyn 
LSP

12 February
Thijs Cohen Tervaert 
INKEF

12 February
Tjarda Molenaar
NVP

13 February
Willemijn Vader 
VitroScan B.V.

13 February
Thomas Hankemeier 
Leiden University

13 February
Henk-Jan Guchelaar
Leiden University Medical Center

13 February
Jos Lunenberg
ENPICOM BV

13 February
Peter de With
Eindhoven University of Technology

13 February
Natal van Riel
Eindhoven University of Technology

13 February
Bart van Zijll Langhout
Janssen Strategic Alliances EMEA & Janssen NL Campus Lead

13 February
Jan Peter Balkenende
Former Prime Minister

13 February
Elena Fernandez-Kleinlein
JLABS EMEA

13 February
Robert Vries
Hubrecht Organoid Technology

13 February
Peter Roevens
Janssen Pharmaceutica NV

13 February
Stefan Luzi
Gilde Healthcare

13 February
Peter Haasjes
Nextgenventures

12 February
Brigitte Drees 
Pivot Park

12 February
Femke van de Hoef
Loyens & Loeff

12 February
Dries Fransen van de Putte
Loyens & Loeff

12 February
Rob de Ree
Biogeneration Ventures

13 February
Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.